MIS-C is a disease entity associated with COVID-19 and has evolving symptomatology and severity. A deeper understanding of the pathophysiology of MIS-C may lead to better treatment strategies. Due to rapid mutations and the contagious nature of the viral infection, covid-19 infection and associated sequelae remain a threat, and better preventative strategies are needed.